litlas
ログインアカウント作成

Gianpietro Dotti

1999–2026 年に発表

170
論文数
34,072
被引用数
95
h 指数
165
i10 指数

被引用数

Gianpietro Dotti の年別被引用数1975 年: 被引用 1 件1996 年: 被引用 1 件1999 年: 被引用 3 件2000 年: 被引用 5 件2001 年: 被引用 17 件2002 年: 被引用 23 件2003 年: 被引用 25 件2004 年: 被引用 29 件2005 年: 被引用 32 件2006 年: 被引用 43 件2007 年: 被引用 41 件2008 年: 被引用 43 件2009 年: 被引用 102 件2010 年: 被引用 146 件2011 年: 被引用 173 件2012 年: 被引用 161 件2013 年: 被引用 297 件2014 年: 被引用 231 件2015 年: 被引用 341 件2016 年: 被引用 384 件2017 年: 被引用 501 件2018 年: 被引用 685 件2019 年: 被引用 1,528 件2020 年: 被引用 2,000 件2021 年: 被引用 2,076 件2022 年: 被引用 2,002 件2023 年: 被引用 1,723 件2024 年: 被引用 2,505 件2025 年: 被引用 1,511 件2026 年: 被引用 41 件1976〜1995 年は被引用が無いため表示していません1997〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,699 件、この内訳の 28.3%中国: 引用元論文 3,270 件、この内訳の 25.1%ドイツ: 引用元論文 721 件、この内訳の 5.5%イタリア: 引用元論文 524 件、この内訳の 4%イギリス: 引用元論文 503 件、この内訳の 3.9%フランス: 引用元論文 332 件、この内訳の 2.5%オーストラリア: 引用元論文 254 件、この内訳の 2%カナダ: 引用元論文 247 件、この内訳の 1.9%日本: 引用元論文 238 件、この内訳の 1.8%イラン: 引用元論文 236 件、この内訳の 1.8%スペイン: 引用元論文 235 件、この内訳の 1.8%オランダ: 引用元論文 226 件、この内訳の 1.7%
0%28.3%その他 19.7%

機関

分野

  • Medicine63%
  • Immunology and Microbiology12.8%
  • Biochemistry, Genetics and Molecular Biology11.8%
  • Engineering7.5%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Materials Science1.8%
  • その他1.2%

トピック

  • CAR-T cell therapy research18.2%
  • Immunotherapy and Immune Responses7.2%
  • Immune Cell Function and Interaction6.8%
  • Virus-based gene therapy research5.6%
  • Nanoplatforms for cancer theranostics4.1%
  • Cancer Immunotherapy and Biomarkers3.8%
  • その他54.3%

共著者

全論文

検索で開く
  1. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

    著者: Christian Flugel, Robbie G. Majzner, Giedre Krenciute, Gianpietro Dotti, Stanley R. Riddell, Dimitrios L. Wagner, Mohamed Abou‐El‐Enein - Nature Reviews Clinical Oncology 2022 被引用: 508

  2. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment

    著者: Qian Chen, Chao Wang, Xudong Zhang, Guojun Chen, Quanyin Hu, Hongjun Li, Jinqiang Wang, Di Wen, Yuqi Zhang, Yifei Lü, Guang Yang, Chen Jiang, Jun Wang, Gianpietro Dotti, Zhen Gu - Nature Nanotechnology 2018 被引用: 1,016

  3. HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma

    著者: Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Kevin Bielamowicz, Mamta Kalra, Daniel Landi, Catherine Robertson, Tara Gray, Oumar Diouf, Amanda Wakefield, Alexia Ghazi, Claudia Gerken, Zhongzhen Yi, Aidin Ashoori, Meng-Fen Wu, Hao Liu, Cliona M. Rooney, Gianpietro Dotti, Adrian P. Gee, Jack Su, Yvonne Kew, David S. Baskin, Yi Jonathan Zhang, Pamela New, Bambi Grilley, Milica Stojakovic, John Hicks, Suzanne Z. Powell, Malcolm K. Brenner, Helen E. Heslop, Robert G. Grossman, Winfried S. Wels, Stephen Gottschalk - JAMA Oncology 2017 被引用: 837

  4. Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets

    著者: Quanyin Hu, Hongjun Li, Edikan Archibong, Qian Chen, Huitong Ruan, Sarah Ahn, Elena Dukhovlinova, Yang Kang, Di Wen, Gianpietro Dotti, Zhen Gu - Nature Biomedical Engineering 2021 被引用: 371

  5. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

    著者: Yang Xu, Ming Zhang, Carlos A. Ramos, April Durett, Enli Liu, Olga Dakhova, Hao Liu, Chad J. Creighton, Adrian P. Gee, Helen E. Heslop, Cliona M. Rooney, Barbara Savoldo, Gianpietro Dotti - Blood 2014 被引用: 736

  6. Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

    著者: Antonio Di Stasi, Siok‐Keen Tey, Gianpietro Dotti, Yuriko Fujita, Alana A. Kennedy‐Nasser, Caridad Martinez, Karin Straathof, Enli Liu, April Durett, Bambi Grilley, Hao Liu, Carolina Colli Cruz, Barbara Savoldo, Adrian P. Gee, John Schindler, Robert A. Krance, Helen E. Heslop, David M. Spencer, Cliona M. Rooney, Malcolm K. Brenner - New England Journal of Medicine 2011 被引用: 1,495

  7. Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

    著者: Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Catherine Robertson, Alexia Ghazi, Claudia Gerken, Enli Liu, Olga Dakhova, Aidin Ashoori, Amanda Corder, Tara Gray, Meng-Fen Wu, Hao Liu, John Hicks, Nino Rainusso, Gianpietro Dotti, Zhuyong Mei, Bambi Grilley, Adrian P. Gee, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Winfried S. Wels, Lisa L. Wang, Peter M. Anderson, Stephen Gottschalk - Journal of Clinical Oncology 2015 被引用: 979

  8. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

    著者: Andras Heczey, Chrystal U. Louis, Barbara Savoldo, Olga Dakhova, April Durett, Bambi Grilley, Hao Liu, Mengfeng F. Wu, Zhuyong Mei, Adrian P. Gee, Birju Mehta, Huimin Zhang, Nadia Mahmood, Haruko Tashiro, Helen E. Heslop, Gianpietro Dotti, Cliona M. Rooney, Malcolm K. Brenner - Molecular Therapy 2017 被引用: 530

  9. Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

    著者: Andras Heczey, Xin Xu, Amy N. Courtney, Gengwen Tian, Gabriel A. Barragán, Linjie Guo, Claudia Martínez-Amador, Nisha Ghatwai, Purva Rathi, Michael S. Wood, Yanchuan Li, Chunchao Zhang, Thorsten Demberg, Erica J. Di Pierro, Andrew C. Sher, Huimin Zhang, Birju Mehta, Sachin G. Thakkar, Bambi Grilley, Tao Wang, Brian Weiss, Antonino Montalbano, Meena Subramaniam, Chenling Xu, Chirag Sachar, Daniel K. Wells, Gianpietro Dotti, Leonid S. Metelitsa - Nature Medicine 2023 被引用: 189

  10. Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

    著者: Meenakshi Hegde, Malini Mukherjee, Zakaria Grada, Antonella Pignata, Daniel Landi, Shoba A. Navai, Amanda Wakefield, Kristen Fousek, Kevin Bielamowicz, Kevin Chow, Vita S. Brawley, Tiara T. Byrd, Simone Krebs, Stephen Gottschalk, Winfried S. Wels, Matthew L. Baker, Gianpietro Dotti, Maksim Mamonkin, Malcolm K. Brenner, Jordan S. Orange, Nabil Ahmed - Journal of Clinical Investigation 2016 被引用: 672

  11. Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

    著者: Chrystal U. Louis, Barbara Savoldo, Gianpietro Dotti, Martin Pulé, Eric Yvon, Gary D. Myers, Claudia Rössig, Heidi V. Russell, Oumar Diouf, Enli Liu, Hao Liu, Meng-Fen Wu, Adrian P. Gee, Zhuyong Mei, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner - Blood 2011 被引用: 1,171

  12. In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy

    著者: Chao Wang, Jinqiang Wang, Xudong Zhang, Shuangjiang Yu, Di Wen, Quanyin Hu, Yanqi Ye, Hunter N. Bomba, Xiuli Hu, Zhuang Liu, Gianpietro Dotti, Zhen Gu - Science Translational Medicine 2018 被引用: 579

  13. Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells

    著者: Pritha Agarwalla, Edikan A. Ogunnaike, Sarah Ahn, Kristen Froehlich, Anton Jansson, Frances S. Ligler, Gianpietro Dotti, Yevgeny Brudno - Nature Biotechnology 2022 被引用: 192

  14. Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors

    著者: Koichi Hirabayashi, Hongwei Du, Yang Xu, Peishun Shou, Xin Zhou, Giovanni Fucà, Elisa Landoni, Chuang Sun, Yu‐Hui Chen, Barbara Savoldo, Gianpietro Dotti - Nature Cancer 2021 被引用: 209

  15. STING agonist promotes CAR T cell trafficking and persistence in breast cancer

    著者: Nuo Xu, Douglas C. Palmer, Alexander C. Robeson, Peishun Shou, Hemamalini Bommiasamy, Sonia J. Laurie, Caryn Willis, Gianpietro Dotti, Benjamin G. Vincent, Nicholas P. Restifo, Jonathan S. Serody - The Journal of Experimental Medicine 2020 被引用: 188

  16. Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

    著者: Andras Heczey, Amy N. Courtney, Antonino Montalbano, Simon N. Robinson, Liu Ka, Mingmei Li, Nisha Ghatwai, Olga Dakhova, Bin Liu, Tali Raveh-Sadka, Cynthia Chauvin, Xin Xu, Ho Ngai, Erica J. Di Pierro, Barbara Savoldo, Gianpietro Dotti, Leonid S. Metelitsa - Nature Medicine 2020 被引用: 276

  17. Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

    著者: Pavel Sumazin, Andras Heczey, John M. Maris, Antonino Montalbano, Amy N. Courtney, Jennifer Pogoriler, Sachin G. Thakkar, Gianpietro Dotti, David Steffin, Premal Lulla, Natalia Lapteva, Dolores López‐Terrada, Zhuyong Mei, Carlos A. Ramos, Malcolm K. Brenner, Ramy Sweidan, Stephen Gottschalk, Huimin Zhang, Nisha Ghatwai, Navin Varadarajan, Leonid S. Metelitsa, Kalyani Patel, Helen E. Heslop, Azlann Arnett, Prakash Masand, Tao Wang, Tannaz Armaghany, Julien Fleurence, Purva Rathi, Bambi Grilley, Daniel Martínez, Deborah Lyon - Nature 2024 被引用: 207

  18. An inducible caspase 9 safety switch for T-cell therapy

    著者: Karin Straathof, Martin Pulé, Patricia Yotnda, Gianpietro Dotti, Elio F. Vanin, Malcolm K. Brenner, Helen E. Heslop, David M. Spencer, Cliona M. Rooney - Blood 2005 被引用: 741

  19. Catch me if you can: how AML and its niche escape immunotherapy

    著者: Sarah Tettamanti, Alice Pievani, Andrea Biondi, Gianpietro Dotti, Marta Serafini - Leukemia 2021 被引用: 206

  20. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

    著者: Martin Pulé, Barbara Savoldo, Gary D. Myers, Claudia Rössig, Heidi V. Russell, Gianpietro Dotti, M. Helen Huls, Enli Liu, Adrian P. Gee, Zhuyong Mei, Éric Yvon, Heidi L. Weiss, Hao Liu, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner - Nature Medicine 2008 被引用: 1,190

  21. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

    著者: Carlos A. Ramos, Natalie S. Grover, Anne Beaven, Premal Lulla, Meng-Fen Wu, Anastasia Ivanova, Tao Wang, Thomas C. Shea, Cliona M. Rooney, Christopher Dittus, Steven I. Park, Adrian P. Gee, Paul W. Eldridge, Kathryn McKay, Birju Mehta, Catherine Cheng, Faith Brianne Buchanan, Bambi Grilley, Kaitlin Morrison, Malcolm K. Brenner, Jonathan S. Serody, Gianpietro Dotti, Helen E. Heslop, Barbara Savoldo - Journal of Clinical Oncology 2020 被引用: 380

  22. In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

    著者: Carlos A. Ramos, Rayne H. Rouce, Catherine Robertson, A. Reyna, Neeharika Narala, Gayatri Vyas, Birju Mehta, Huimin Zhang, Olga Dakhova, George Carrum, Rammurti T. Kamble, Adrian P. Gee, Zhuyong Mei, Meng-Fen Wu, Hao Liu, Bambi Grilley, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Barbara Savoldo, Gianpietro Dotti - Molecular Therapy 2018 被引用: 293

  23. Cryo-shocked cancer cells for targeted drug delivery and vaccination

    著者: Tianyuan Ci, Hongjun Li, Guojun Chen, Zejun Wang, Jinqiang Wang, Peter Abdou, Yiming Tu, Gianpietro Dotti, Zhen Gu - Science Advances 2020 被引用: 187

  24. Interleukin-23 engineering improves CAR T cell function in solid tumors

    著者: Xingcong Ma, Peishun Shou, Christof C. Smith, Yu‐Hui Chen, Hongwei Du, Chuang Sun, Nancy P. Kren, Daniel Michaud, Sarah Ahn, Benjamin G. Vincent, Barbara Savoldo, Yuliya Pylayeva‐Gupta, Shuqun Zhang, Gianpietro Dotti, Yang Xu - Nature Biotechnology 2020 被引用: 243